Terms: = Thyroid cancer AND MUC16, CA125, CA-125
80 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
3. Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays.
Galior KD; Ladwig PM; Snyder MR; Algeciras-Schimnich A; Bornhorst JA; Block DR; Baumann NA; Willrich MAV
Clin Biochem; 2023 Nov; 121-122():110685. PubMed ID: 37972806
[TBL] [Abstract] [Full Text] [Related]
4.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
5. A Curious Case of Omental Oxalate Crystals in a Patient With Struma Ovarii: Pointers to an Unusual Clinicopathological Scenario.
Bakshi N; Dhawan S; Rao S; Arora A
Int J Surg Pathol; 2024 Apr; 32(2):414-417. PubMed ID: 37287245
[TBL] [Abstract] [Full Text] [Related]
6. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
7. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
Zhang J; Zhang J; Han J
Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
[TBL] [Abstract] [Full Text] [Related]
8. Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature.
Zhang R; Tian X; Luo Y; Dong H; Tian W; Zhang Y; Li D; Sun H; Meng Z
Pathol Oncol Res; 2022; 28():1610221. PubMed ID: 35620742
[No Abstract] [Full Text] [Related]
9. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, cancer Antigen 153 and cancer Antigen 125 in Metastatic Breast cancer.
Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.
Moskovich D; Finkelshtein Y; Alfandari A; Rosemarin A; Lifschytz T; Weisz A; Mondal S; Ungati H; Katzav A; Kidron D; Mugesh G; Ellis M; Lerer B; Ashur-Fabian O
Oncogene; 2021 Nov; 40(44):6248-6257. PubMed ID: 34556811
[TBL] [Abstract] [Full Text] [Related]
11. Hyperthyroidism associated with
Podfigurna A; Szeliga A; Horwat P; Maciejewska-Jeske M; Meczekalski B
Gynecol Endocrinol; 2021 Dec; 37(12):1143-1150. PubMed ID: 34387530
[TBL] [Abstract] [Full Text] [Related]
12. Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.
Akahane T; Kanomata N; Harada O; Yamashita T; Kurebayashi J; Tanimoto A; Moriya T
BMC Cancer; 2020 Oct; 20(1):944. PubMed ID: 33004031
[TBL] [Abstract] [Full Text] [Related]
13. Postoperative expressions of TRACP5b and ca125 in patients with breast cancer and their values for monitoring bone metastasis.
Feng C; Zhan Y; Shao H; Wang Z; Zhu S
J BUON; 2020; 25(2):688-695. PubMed ID: 32521854
[TBL] [Abstract] [Full Text] [Related]
14. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases.
Guo Y; Wang J; Li Y; Wang Y
Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758
[TBL] [Abstract] [Full Text] [Related]
15. Papillary thyroid carcinoma in Struma Ovarii.
Khatchapuridze K; Kekelidze N; Tsitsishvili Z; Mchedlishvili M; Kordzaia D
Gynecol Endocrinol; 2020 Aug; 36(8):749-752. PubMed ID: 32041443
[TBL] [Abstract] [Full Text] [Related]
16. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
17. Ovarian cancer metastasis to the breast 18 years after the initial diagnosis: A case report.
Wang Z; Zhao D; Liu R; Zheng B
Medicine (Baltimore); 2019 Oct; 98(43):e17577. PubMed ID: 31651861
[TBL] [Abstract] [Full Text] [Related]
18. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks' gestation in naturally conceived and uncomplicated pregnancies resulting in live births.
Friis Petersen J; Friis-Hansen LJ; Jensen AK; Nyboe Andersen A; Løkkegaard ECL
Clin Chem Lab Med; 2019 Nov; 57(12):1956-1967. PubMed ID: 31343977
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
[TBL] [Abstract] [Full Text] [Related]
20. Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review.
Ando H; Watanabe Y; Ogawa M; Tamura H; Deguchi T; Ikeda K; Fujitani M; Shioji M; Tsujie T; Doi R; Wakimoto A; Adachi S
Diagn Pathol; 2017 Aug; 12(1):63. PubMed ID: 28841919
[TBL] [Abstract] [Full Text] [Related]
[Next]